secwatch.observer — SEC 8-K summary
======================================

Issuer:     Incannex Healthcare Inc. (IXHL)
CIK:        0001873875
Form:       8-K
Filed at:   2025-07-25T23:59:59+00:00
Accession:  0001213900-25-067474
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Incannex appoints Dr. Gamaldo to OSA advisory board; Phase 2 data due next week
-------------------------------------------------------------------------------

- Dr. Charlene E. Gamaldo (Johns Hopkins professor) joins IHL-42X Obstructive Sleep Apnea Clinical Advisory Board.
- Phase 2 data readout for IHL-42X expected next week, per CMO Dr. Lou Barbato.
- Gamaldo has joint appointments in neurology, psychiatry, nursing, anesthesiology, and public health.
- She has authored >120 scholarly works and received multiple sleep medicine leadership awards.
- Appointment reflects Incannex's growing confidence in IHL-42X and commitment to scientific rigor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1873875/000121390025067474/0001213900-25-067474-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1873875/000121390025067474/ea0250114-8k_incannex.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-067474

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer